importantSYS.SOURCE: CERN Courier• 2026-10-10T00:13:16Z

Precision Measurement of the Strong Coupling Constant in QCD

#qcd #lattice calculations #strong coupling #particle physics #precision measurement

The article details the precise determination of the strong coupling constant αs in quantum chromodynamics (QCD) using lattice QCD, reducing its uncertainty to five parts per mille. This advancement enhances the accuracy of collider predictions and supports future high-precision experiments like the High-Luminosity LHC and FCC-ee.

Read original article

*** END OF TRANSMISSION ***

> APPLE'S STRATEGIC MOVE: HIRING HUXE TEAM AND LICENSING AI TECHNOLOGY FOR PERSONALIZED PODCASTS > TAKESHI'S CASTLE: JAPANESE TELEVISION GAME SHOW AND INTERNATIONAL ADAPTATIONS > NVIDIA EXPLORES ACQUISITION OF US OPEN-SOURCE AI STARTUP REFLECTION AI > AI-DRIVEN WEB BROWSER PORTS OF CLASSIC GAMES DEMONSTRATE HIGH FUNCTIONALITY > DUCKDB 2.0 PERFORMANCE ENHANCEMENTS: ASYNC I/O AND RECURSIVE CTE OPTIMIZATIONS > PETRA POWER ADVANCES SOLID OXIDE FUEL CELL TECHNOLOGY FOR DATA CENTERS AND DEFENSE APPLICATIONS > CLOUDFLARE ACQUIRES DENO TO ENHANCE WORKERS PROGRAMMING MODEL > DONALD KNUTH'S ERROR REWARD CHECK FOR COMPUTER MODERN TYPEFACES > THE DOMINANCE OF PROTEIN IN BIOLOGICAL SYSTEMS > PHASE 1 CLINICAL TRIAL INITIATED FOR POPVAX'S BROADLY PROTECTIVE COVID-19 VACCINE PVX-001> APPLE'S STRATEGIC MOVE: HIRING HUXE TEAM AND LICENSING AI TECHNOLOGY FOR PERSONALIZED PODCASTS > TAKESHI'S CASTLE: JAPANESE TELEVISION GAME SHOW AND INTERNATIONAL ADAPTATIONS > NVIDIA EXPLORES ACQUISITION OF US OPEN-SOURCE AI STARTUP REFLECTION AI > AI-DRIVEN WEB BROWSER PORTS OF CLASSIC GAMES DEMONSTRATE HIGH FUNCTIONALITY > DUCKDB 2.0 PERFORMANCE ENHANCEMENTS: ASYNC I/O AND RECURSIVE CTE OPTIMIZATIONS > PETRA POWER ADVANCES SOLID OXIDE FUEL CELL TECHNOLOGY FOR DATA CENTERS AND DEFENSE APPLICATIONS > CLOUDFLARE ACQUIRES DENO TO ENHANCE WORKERS PROGRAMMING MODEL > DONALD KNUTH'S ERROR REWARD CHECK FOR COMPUTER MODERN TYPEFACES > THE DOMINANCE OF PROTEIN IN BIOLOGICAL SYSTEMS > PHASE 1 CLINICAL TRIAL INITIATED FOR POPVAX'S BROADLY PROTECTIVE COVID-19 VACCINE PVX-001